Original Research
Accepted on 01 Sep 2025
Synergistic Impact of Dysglycemia and HPV on Cervical Cancer Risk: A Potential Mediating Role of Ki-67
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1422881
Type at least 3 characters
1,276 articles
Original Research
Published on 01 Sep 2025
Management of type I gastric-neuroendocrine tumors: the less the better?
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1666699
- 326 views
Correction
Published on 29 Aug 2025
Correction: The impact of altered gut microbiota and lipid metabolism on the progression of endometrial cancer in overweight populations
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1681661
- 248 views
Mini Review
Published on 29 Aug 2025
Dual-tracer 18F-FDG and 18F-AlF-NOTA-octreotide PET/CT imaging in oncocytic thyroid adenoma: a case report and literature review
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1612851
- 325 views
Original Research
Accepted on 28 Aug 2025
Beyond castration: defining maximal testosterone control in advanced prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1634966
- 163 views
Brief Research Report
Published on 27 Aug 2025
Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1625906
- 1,077 views
Original Research
Published on 26 Aug 2025
Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1644270
- 587 views
Original Research
Accepted on 25 Aug 2025
A Machine Learning Model for Predicting Bone and/or Lung Metastasis in Differentiated Thyroid Carcinoma: Enhancing Precision in Risk Stratification
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1528392
- 277 views
Original Research
Accepted on 25 Aug 2025
Prolactin and DNA Damage Trigger an Anti-Breast Cancer Cell Immune Response
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1586062
- 177 views
Original Research
Published on 25 Aug 2025
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1619875
- 438 views
Review
Published on 25 Aug 2025
Progress of estrogen receptor and spliceosome in endometrial carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1586191
- 527 views
Original Research
Accepted on 22 Aug 2025
Insights into Gastric Mixed Adenoneuroendocrine Carcinoma: A Novel Comparative Study of Clinicopathological Features and Survival Outcomes
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1650314
Original Research
Accepted on 20 Aug 2025
The relationship between remnant cholesterol and WHO grade of pancreatic neuroendocrine neoplasms
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1616523
- 174 views
Original Research
Published on 11 Aug 2025
Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1520539
- 730 views
Original Research
Published on 11 Aug 2025
Clinicopathological features and outcomes in patients with concurrent medullary and papillary thyroid carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1625989
- 711 views
Original Research
Accepted on 08 Aug 2025
Mutation interactions of BRAF and TP53 define novel prognostic stratification and therapeutic implications in papillary thyroid carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1584618
- 303 views